Biotech mutual funds and ETFs recorded $1.5 billion net outflows for the week ending Wednesday, a 1.53% asset decline across 130 funds.
Year‑to‑date outflows total $1.98 billion, marking the sector’s second consecutive week of net withdrawals.
The breadth ratio rose to 0.48 from 0.45; a 0.28 ratio on July 16 preceded a 36% Nasdaq Biotechnology Index gain.
Historical data shows a 0.3 breadth ratio typically triggers a 17.5% sector rally over the following six months.